Avadel pharmaceuticals to provide a corporate update and report fourth quarter and full year 2024 financial results on march 3

Dublin, feb. 24, 2025 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:30 a.m. et on monday, march 3, 2025, to provide a corporate update and discuss the company's financial results for the fourth quarter and full year ended december 31, 2024.
AVDL Ratings Summary
AVDL Quant Ranking